 |
 Video: What is a Stock Split?
|
|
|
| Pulse Biosciences is a bioelectric medicine company focused on health innovation using its patented Nano-Pulse Stimulation (NPS) technology, an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as a Nanosecond Pulsed-Field Ablation (nsPFA) technology when used to ablate cellular tissue. The CellFX System is a software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. The CellFX System is configured to accept a variety of handpieces or electrodes. According to our Pulse Biosciences stock split history records, Pulse Biosciences has had 0 splits. | |
|
Pulse Biosciences (PLSE) has 0 splits in our Pulse Biosciences stock split history database.
Looking at the Pulse Biosciences stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Pulse Biosciences shares, starting with a $10,000 purchase of PLSE, presented on a split-history-adjusted basis factoring in the complete Pulse Biosciences stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/19/2016 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$4.08 |
|
| End price/share: |
$7.36 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
80.39% |
|
| Average Annual Total Return: |
7.73% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$18,035.33 |
|
| Years: |
7.92 |
|
|
|
|
|
